№ lp_2_3_59708
File format: docx
Character count: 5224
File size: 178 KB
This document provides instructions for self-administration of the Sayana® Press contraceptive injection and outlines important safety information for users.
Year:
2021
Region / City:
Bilbrook
Topic:
Contraception
Document Type:
Patient Information Leaflet
Organization / Institution:
Bilbrook Medical Centre
Author:
Bilbrook Medical Centre
Target Audience:
Patients using Sayana® Press
Duration:
13 weeks
Approval Date:
May 2021
Review Date:
May 2023
Changes Date:
N/A
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Version:
3.1
Date:
January 2026
Location/Service/Organisation:
[location/service/organisation]
PGD Development Group:
Reproductive Health PGDs Short Life Working Group
Reviewed by:
College of Sexual and Reproductive Health (CoSRH)
Date Template Comes into Effect:
1st April 2026
Review Date:
1st September 2028
Expiry Date:
31st March 2029
Year:
N/A
Region / City:
Sub-Saharan Africa
Subject:
Health workers, contraceptives, knowledge, attitudes, practices
Document Type:
Search strategy
Organization / Institution:
N/A
Author:
N/A
Target Audience:
Researchers, healthcare professionals
Period of Validity:
N/A
Date of Approval:
N/A
Date of Changes:
N/A
Year:
2013
Region / City:
Cocke County, Sevier County, East Tennessee
Topic:
Substance Use and Abuse
Document Type:
Report
Organization:
Tennessee Department of Health
Author:
Erica Wilson, M.P.H.
Target Audience:
Female inmates, health professionals, community partners
Period of Implementation:
January 30, 2014 - September 2014
Approval Date:
January 30, 2014
Modification Date:
February 7, 2014
Program:
Voluntary Reversible Long Acting Contraceptive (VRLAC) Jail Initiative
Outreach Partners:
UT Medical Center Family Medical Residency Program
Number of Participants:
142 women
Project Contact:
Erica Wilson, M.P.H.
Contact Information:
4310 Papermill Rd. Knoxville, TN 37909-2018, 865-909-9404 Ext. 103, [email protected]
Context:
A public health report describing a pilot project aimed at educating female inmates in East Tennessee jails about NAS and offering voluntary reversible long-acting contraceptives (VRLAC) to prevent NAS births.
Note:
Year
Topic:
Oral contraception, Health review
Document type:
Medical form
Organization / institution:
South View Partnership
Target audience:
Patients requesting repeat oral contraceptive prescriptions
Period of validity:
Annual
Year:
2012
Region / City:
Nairobi, Kenya
Subject:
Reproductive Health, Contraceptive Training
Document Type:
Official Letter
Organization:
Ministry of Public Health and Sanitation, Tupange – Kenya Urban Reproductive Health Initiative
Author:
Nelson Keyonzo
Target Audience:
Health service providers
Training Dates:
23–27 April 2012, 30 April–4 May 2012
Contact:
Emmah Kariuki, Tel. 0721 759646
Partners:
Jhpiego, Johns Hopkins University Center for Communication Programs, Marie Stopes International, NCAPD, Pharm Access Africa
Year:
2026
Region / City:
Global
Topic:
Reproductive Health
Document Type:
Informational Guide
Institution / Organization:
Not specified
Author:
Not specified
Target Audience:
Individuals seeking knowledge on fertility and contraception
Methods Covered:
Natural Family Planning, Cervical Mucus Method, Condoms, Diaphragm, Mini-pill, Injection, Implant, Intrauterine System, Intrauterine Device
Usage Instructions:
Detailed for each method
Benefits and Risks:
Provided for each method
Year:
2025
Region / Location:
[location/service/organisation]
Document Type:
Patient Group Direction (PGD)
Issuing Organization:
College of Sexual and Reproductive Healthcare (CoSRH)
Authors / Contributors:
Alison Crompton, Bola Sotubo, Carmel Lloyd, Dr Cindy Farmer, Clare Livingstone, Dipti Patel, Emma Anderson, Heather Randle, Julia Hogan, Kate Devonport, Kirsty Armstrong, Lisa Knight, Michelle Jenkins, Portia Jackson, Rachel Logan, Tanya Lane, Jo Jenkins, Kieran Reynolds, Rosie Furner, Sandra Wolper
Intended Users:
Registered healthcare professionals authorized to operate under the PGD
Implementation Date:
1st April 2026
Review Date:
1st September 2028
Expiry Date:
31st March 2029
Version History:
Version 1 (April 2020), Version 1.1 (November 2020), Version 2.0 (April 2023), Version 2.1 (April 2024), Version 2.2 (April 2025), Version 2.3 (July 2025), Version 3.0 (October 2025)
Regulatory Reference:
Human Medicines Regulation 2012, Schedule 16 Part 4
Approval:
College of Sexual and Reproductive Healthcare (CoSRH), January 2026
Supporting Groups:
Reproductive Health PGDs Short Life Working Group (SLWG)
Contextual Scope:
Contraceptive medicine administration and patient safety guidelines
Year:
2024
Region / city:
Barnet
Topic:
EBSA (Emotional Based School Avoidance)
Document type:
Guidance
Institution:
Partnership for Jewish Schools (PaJeS)
Author:
Sinéad O’Callaghan, Kim Miller, Lisa Coffman, Julia Alberga, Jessica Overlander-Kaye, Abigail Freedman, Bracha Hackner, Caron Aspis, Daniel Weisberg, Hannah Martin, Julia Silver, Keren Greene, Naomi Simon, Samantha Cohen, Sara Levan, Sarah Bronzite, Sasha Sharpe, Sophie Driver, Shiri Lader, Suzanne Jaeger, William Hemens
Target audience:
Families and professionals supporting children experiencing EBSA in Jewish schools
Action period:
2024 onwards
Approval date:
2024
Modification date:
Not specified
Note:
Year
Topic:
Data protection, research ethics, participant consent
Document Type:
Template
Target audience:
Researchers conducting non-health-related studies involving personal data
Organisation:
Odiham and Old Basing Health Centres
Type of document:
Patient leaflet
Region:
Hampshire, England
Healthcare system:
NHS
Facilities:
Odiham Health Centre; Old Basing Health Centre
Services covered:
General practice; primary care; community health services
Opening hours:
Monday–Friday
Appointment system:
Telephone triage; face-to-face appointments; online booking
Out-of-hours care:
NHS 111
Emergency contact:
999
Training status:
GP training practice
Patient engagement:
Patient Participation Group
Document audience:
Registered patients and prospective patients
Document purpose:
Patient information and service overview
Contact details included:
Telephone; email; website
Accessibility information:
Parking; disabled access; wheelchair availability
Note:
Year
Region / City:
Barrow in Furness, Cumbria
Subject:
Healthcare Services
Document Type:
Information Leaflet
Organization:
Duke Street Surgery
Target Audience:
Patients of Duke Street Surgery
Context:
A leaflet detailing the healthcare services offered by Duke Street Surgery, including appointments, prescriptions, and various medical services.
Year:
2023
Region / City:
Tallaght, Dublin
Topic:
Research Ethics, Data Protection
Document Type:
Template
Organization:
St James’s Hospital / Tallaght University Hospital
Author:
Joint Research Ethics Committee
Target Audience:
Researchers, Adult Participants, Patients, Parents, Carers
Period of Validity:
N/A
Approval Date:
N/A
Date of Last Update:
N/A
Document No:
FDA/DNC/TEM-02
Date of First Adoption:
1st February 2013
Date of Issue:
8th January 2024
Version No:
03
Issuing Authority:
Food and Drugs Authority, Ghana
Acknowledgement:
World Health Organization (WHO)
Type of Document:
Patient Information Leaflet (PIL)
Target Audience:
Patients and healthcare providers
Content:
Instructions, warnings, side effects, storage, and pharmaceutical information of the medicine
Year:
2019
Regulation:
EU 2019/6
Document type:
Guidance template
Author:
European Union
Target audience:
Applicants of veterinary medicinal products
Approval date:
Not specified
Modification date:
Not specified
Description:
Template for packaging label and leaflet for veterinary medicinal products intended to be included on the immediate packaging, as outlined by EU regulation.
Note:
Year
Topic:
Data Protection, Research Ethics
Document Type:
Guidance
Institution:
Trinity College Dublin
Author:
Trinity College Dublin Data Protection Office
Target Audience:
Researchers
Year:
2023
Region / City:
Ireland
Subject:
Health research, Data protection
Document type:
Guidance document
Institution:
Trinity College Dublin
Author:
Data Protection Office
Target audience:
Researchers conducting health research
Period of validity:
Not specified
Approval date:
Not specified
Date of amendments:
Not specified
Year:
2023
Region / city:
Global
Topic:
Pharmaceutical Information
Document Type:
Patient Information Leaflet (PIL)
Organization / Institution:
World Health Organization (WHO)
Author:
WHO Prequalification Team
Target Audience:
Patients, healthcare providers
Validity Period:
Not specified
Approval Date:
Not specified
Date of Amendments:
Not specified
Year:
2026
Region / City:
Russian Federation
Type:
Patient information leaflet
Product:
Grippol® Quadrivalent
Therapeutic group:
Vaccine against influenza (inactivated) with adjuvant
Dosage form:
Solution for intramuscular and subcutaneous injection
Active ingredients:
Influenza virus antigens A(H1N1), A(H3N2), B Yamagata, B Victoria, Azoximer bromide
Indications:
Influenza prophylaxis for children over 6 years, adolescents, adults under 60 years, high-risk and occupational groups
Contraindications:
Allergy to chicken proteins or vaccine components, age under 6, pregnancy (for preservative-containing vaccine), acute illness
Administration:
Intramuscular or deep subcutaneous injection, 0.5 ml per dose, annual vaccination
Storage conditions:
2–8 °C, protect from contamination, follow aseptic rules
Regulatory status:
Marketing authorization in Russia